# Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

> **NCT03418831** · PHASE4 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 45 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Raloxifene Hydrochloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03418831
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-17
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-07-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03418831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03418831, "Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03418831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*